Company registration number 15933001 (England and Wales)
PRECISION THEATRE INVESTMENTS LIMITED
UNAUDITED FINANCIAL STATEMENTS
FOR THE PERIOD ENDED 31 MARCH 2026
PAGES FOR FILING WITH REGISTRAR
PRECISION THEATRE INVESTMENTS LIMITED
CONTENTS
Page
Balance sheet
1
Notes to the financial statements
2 - 3
PRECISION THEATRE INVESTMENTS LIMITED
BALANCE SHEET
AS AT
31 MARCH 2026
31 March 2026
- 1 -
31 March 2026
30 September 2025
Notes
£
£
£
£
Current assets
Cash at bank and in hand
129
-
0
Creditors: amounts falling due within one year
3
(1,320)
-
0
Net current liabilities
(1,191)
-
0
Capital and reserves
Called up share capital
-
0
-
0
Profit and loss reserves
(1,191)
-
0
Total equity
(1,191)
-
0

For the financial period ended 31 March 2026 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

The members have not required the company to obtain an audit of its financial statements for the period in question in accordance with section 476.

The director acknowledges his responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of financial statements.

These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

The director of the company has elected not to include a copy of the profit and loss account within the financial statements.true

The financial statements were approved and signed by the director and authorised for issue on 23 June 2026
Ramin Sabi
Director
Company registration number 15933001 (England and Wales)
PRECISION THEATRE INVESTMENTS LIMITED
NOTES TO THE FINANCIAL STATEMENTS
FOR THE PERIOD ENDED 31 MARCH 2026
- 2 -
1
Accounting policies
Company information

Precision Theatre Investments Limited is a private company limited by shares incorporated in England and Wales. The registered office is Fox Court, 14 Gray's Inn Road, C/O Dem Productions, London, England, WC1X 8HN.

1.1
Reporting period

The current period figures relate to the period ended from 1 October 2025 to 31 March 2026. The comparative period figures cover the period from date of incorporation, 3 September 2024 to 30 September 2025.

1.2
Basis of preparation

These financial statements have been prepared in accordance with FRS 102 “The Financial Reporting Standard applicable in the UK and Republic of Ireland” (“FRS 102”) and the requirements of the Companies Act 2006 as applicable to companies subject to the small companies regime. The disclosure requirements of section 1A of FRS 102 have been applied other than where additional disclosure is required to show a true and fair view.

The financial statements are prepared in sterling, which is the functional currency of the company. Monetary amounts in these financial statements are rounded to the nearest £.

The financial statements have been prepared under the historical cost convention. The principal accounting policies adopted are set out below.

1.3
Going concern

Atruet the time of approving the financial statements, the director has a reasonable expectation that the company has adequate resources to continue in operational existence for the foreseeable future. Thus the director continues to adopt the going concern basis of accounting in preparing the financial statements.

1.4
Financial instruments

The company has elected to apply the provisions of Section 11 ‘Basic Financial Instruments’ and Section 12 ‘Other Financial Instruments Issues’ of FRS 102 to all of its financial instruments.

 

Financial instruments are recognised in the company's balance sheet when the company becomes party to the contractual provisions of the instrument.

 

Financial assets and liabilities are offset, with the net amounts presented in the financial statements, when there is a legally enforceable right to set off the recognised amounts and there is an intention to settle on a net basis or to realise the asset and settle the liability simultaneously.

Basic financial assets

Basic financial assets, which include debtors and cash and bank balances, are initially measured at transaction price including transaction costs and are subsequently carried at amortised cost using the effective interest method unless the arrangement constitutes a financing transaction, where the transaction is measured at the present value of the future receipts discounted at a market rate of interest. Financial assets classified as receivable within one year are not amortised.

Classification of financial liabilities

Financial liabilities and equity instruments are classified according to the substance of the contractual arrangements entered into. An equity instrument is any contract that evidences a residual interest in the assets of the company after deducting all of its liabilities.

Basic financial liabilities

Basic financial liabilities, includes loans from fellow group companies that are classified as debt, are initially recognised at transaction price unless the arrangement constitutes a financing transaction, where the debt instrument is measured at the present value of the future payments discounted at a market rate of interest. Financial liabilities classified as payable within one year are not amortised.

PRECISION THEATRE INVESTMENTS LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE PERIOD ENDED 31 MARCH 2026
- 3 -
2
Employees

There were no employees during the current or comparative period.

 

3
Creditors: amounts falling due within one year
2026
2025
£
£
Other creditors
370
-
0
Accruals and deferred income
950
-
0
1,320
-
0
2026-03-312025-10-01falsefalsefalse23 June 2026CCH SoftwareCCH Accounts Production 2026.100No description of principal activityRamin SabiBenjamin Hunt0159330012025-10-012026-03-31159330012026-03-31159330012025-09-3015933001core:CurrentFinancialInstrumentscore:WithinOneYear2026-03-3115933001core:CurrentFinancialInstrumentscore:WithinOneYear2025-09-3015933001core:ShareCapital2026-03-3115933001core:ShareCapital2025-09-3015933001core:RetainedEarningsAccumulatedLosses2026-03-3115933001core:RetainedEarningsAccumulatedLosses2025-09-3015933001bus:Director12025-10-012026-03-3115933001bus:PrivateLimitedCompanyLtd2025-10-012026-03-3115933001bus:SmallCompaniesRegimeForAccounts2025-10-012026-03-3115933001bus:FRS1022025-10-012026-03-3115933001bus:AuditExemptWithAccountantsReport2025-10-012026-03-3115933001bus:CompanySecretary12025-10-012026-03-3115933001bus:FullAccounts2025-10-012026-03-31xbrli:purexbrli:sharesiso4217:GBP